Author(s):
Anu Singh, Purnima Bharati, Vinita Singh, Ratna Chowdhary
Email(s):
purnimamgm@gmail.com
DOI:
10.52711/0974-360X.2024.00076 
Address:
Anu Singh1, Purnima Bharati2*, Vinita Singh, Ratna Chowdhary
1Assistant Professor, Department of Pathology, Institute of Medical Sciences BHU, Varanasi, Uttar Pradesh, India.
2Assistant Professor, Department of Pathology, Sheikh Bhikhari Medical College, Hazaribag, Jharkhand, India.
3Additional Professor, Department of Obstetrics and Gynaecology, AIIMS Raipur, Chattisgadh, India.
4Professor, Department of Pathology, RIMS Ranchi, Jharkhand, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 2,
Year - 2024
ABSTRACT:
Background: To compare the expression of ER, PR, and Her-2/neu in cases of endometrial hyperplasia and endometrial carcinoma within glands and stroma with normal endometrium. Methods: Samples of formalin-fixed, paraffin-embedded tissue of 62 patients coming to a tertiary care center were immunohistochemically studied for expression of ER and PR. Results: Steroid Hormone receptor levels of both ER and PR were overexpressed in endometrial hyperplasia and carcinoma compared to normal endometrium. However, same was significantly reduced in adenocarcinoma compared to simple hyperplasia and revealed a statistical significance with a p-value <0.05. Conclusions: Immunohistochemical expression of ER and PR should be evaluated in all cases of simple and atypical hyperplasia, and adenocarcinoma as their expression can facilitate a prognostic marker and can entail hormonal therapy in future for such cases.
Cite this article:
Anu Singh, Purnima Bharati, Vinita Singh, Ratna Chowdhary. An Immunohistochemical Study to assess the Expression of Estrogen and Progesterone Receptor in Endometrial hyperplasia and Endometrial carcinoma compared to normal Endometrium: A Prospective Pathological Study. Research Journal of Pharmacy and Technology. 2024; 17(2):491-5. doi: 10.52711/0974-360X.2024.00076
Cite(Electronic):
Anu Singh, Purnima Bharati, Vinita Singh, Ratna Chowdhary. An Immunohistochemical Study to assess the Expression of Estrogen and Progesterone Receptor in Endometrial hyperplasia and Endometrial carcinoma compared to normal Endometrium: A Prospective Pathological Study. Research Journal of Pharmacy and Technology. 2024; 17(2):491-5. doi: 10.52711/0974-360X.2024.00076 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-2-4
REFERENCES:
1. Soper JT, Segreti EM, Novotny DB, Mutch D, Creasman WT, McCarty KS Jr. Estrogen and progesterone receptor content of endometrial carcinomas: comparison of total tissue versus cancer component analysis. Gynecol Oncol. 1990; 36(3):363-8.
2. Vilgelm A, Lian Z, Wang H, Beauparlant SL, Klein-Szanto A, Ellenson LH, Di Cristofano A. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice, Cancer Res. 2006; 66:3375-3380.
3. K S McCarty Jr et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch pathol Lab Med. 1985
4. Nyholm HC, Nielson AL, Lyndrup J, Norup P, Thorpe SM. Biochemical and Immunohistochemical estrogen and progesterone receptors in endometrial hyperplasia and endometrial carcinoma. American Journal of Obstetrics and Gynecology. 1992; 167(5):1334-42.
5. Christine Bergeron, Alex Ferenczy, David O. Toft, and Gopalan Shyamala. Immunocytochemical Study of Progesterone Receptors in Hyperplastic and Neoplastic Endometrial Tissues. Cancer Research. 1988; 48: 6132-6136.
6. Brustein S, Fruchter R, Greene GL, Pertschuk LP. Immunohistochemical assay of estrogen and progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia. Modern Pathology. 1989; 2(5):449-55.
7. Carcangiu ML, Chambers JT, Voynick IM, PirroM, Schwartz PE. Immunohistochemical evaluation of ER and PR content in 183 patients with endometrial carcinoma. American Journal of Clinical Pathology. 1990; 94(3):247-54.
8. Aylin Ege Gul,Sevinc Hallac Keser, Nagehan Ozdemir Barisik, Nilufer Onak Kandemir, Caglar Cakır, Sibel Sensu, Nimet Karadayi. The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas. Diagnostic Pathology. 2010; 5-13.
9. Michelle Reid-Nicholson, Pratibha Iyengar, Amanda J Hummer, Irina Linkov, Marina Asher1 and Robert A Soslow. Immunophenotypic diversity of endometrial adenocarcinomas implications for differential diagnosis. Modern Pathology. 2006; 19: 1091-1100.